LP8-32586-35956
4 vaccinations
3 coded responses
43 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 982 / WA
- Registered
- 2021-04-15
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
CZZ-19267-60009
Child or adolescent in my care · Female · 2022-11-11
Timeline
-
2021-04-15
Registered in v-safe
-
2021-04-15
Dose 1 — Pfizer-BioNTech
-
2021-04-15
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-04-16
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tirednessAdult check-in
- 2021-04-17
- 2021-04-19
- 2021-04-20
- 2021-04-21
- 2021-04-22
- 2021-04-29
- 2021-05-06
-
2021-05-07
Dose 2 — Pfizer-BioNTech
- 2021-05-07
-
2021-05-08
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2021-05-09
- 2021-05-10
- 2021-05-11
- 2021-05-12
- 2021-05-13
- 2021-05-14
- 2021-05-21
- 2021-05-28
- 2021-06-04
- 2021-06-11
- 2021-06-18
-
2021-08-06
Survey response — 3 months, dose 2MedDRA: Headache, Hormone level abnormal — Feeling: FairFree text: Headaches. Undergoing fertility treatments so likely from hormones and associated medications.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-11-05
Survey response — 6 months, dose 2MedDRA: Hypothyroidism, Office visit, Pregnancy — Feeling: Fair · Get care from a doctor or other healthcare professionalFree text: Symptoms: Pregnancy induced hypothyroidism · Healthcare visit (other): General prenatal care visitMedDRA releases: 2024-11 · check-in free text available
-
2021-11-05
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
-
2021-11-08
Dose 3 — Pfizer-BioNTech
- 2021-11-09
- 2021-11-09
- 2021-11-10
- 2021-11-11
- 2021-11-12
- 2021-11-12
- 2021-11-13
- 2021-11-14
- 2021-11-15
- 2021-11-22
- 2021-11-29
- 2021-12-06
- 2021-12-13
-
2021-12-20
Survey response — day 42, dose 3MedDRA: Cough, Diarrhoea, Pre-existing disease — Feeling: GoodFree text: Coughing (likely due to allergies and sleep apnea) and diarrhea (likely due to something I ate)MedDRA releases: 2024-11 · check-in free text available
- 2022-02-07
- 2022-05-09
-
2022-10-03
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-11-08
- 2022-11-11
- 2022-11-14
- 2023-01-02
- 2023-04-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-15 | Pfizer-BioNTech | |
| 2 | 2021-05-07 | Pfizer-BioNTech | |
| 3 | 2021-11-08 | Pfizer-BioNTech | No |
| 4 | 2022-10-03 | Pfizer-BioNTech | Flu |
Call center
1 call center case
1 unsuccessful
Free text
Release 9 — 3 months, dose 2
Symptoms: Headaches. Undergoing fertility treatments so likely from hormones and associated medications.
Release 10 — 6 months, dose 2
Symptoms: Pregnancy induced hypothyroidism
Healthcare visit (other): General prenatal care visit
Release 10 — day 42, dose 3
Symptoms: Coughing (likely due to allergies and sleep apnea) and diarrhea (likely due to something I ate)
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Headache | ✓ | · | ✓ |
| SD | Hormone level abnormal | ✓ | · | ✓ |
| SD | Hypothyroidism | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Pregnancy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release